Diabetes Mellitus Type 2 in Obese Clinical Trial
Official title:
The Effect of Reiki on Treatment Compliance, Eating Behaviors and Metabolic Values in Obese Individuals With Type 2 Diabetes": Randomized Controlled Study
The increase in the prevalence of diabetes and the loss of various organs and functions in the individual as a result of complications caused by diabetes affect the life expectancy and quality of individuals, and cause social and economic losses affecting the whole society. For this reason, the individual management of the diabetic patient is important in terms of ensuring effective participation and compliance in treatment and care. Patients must have knowledge, skills and positive attitudes in order to successfully comply with diabetes treatment. Patients are in compliance with diabetes treatment; they encounter some barriers such as medication barriers, barriers to self-monitoring, knowledge and belief barriers, barriers to diagnosis, barriers in relations with health professionals, barriers to lifestyle change, barriers to coping with diabetes, and barriers to getting advice and support. The American Diabetes Association (ADA) states that self-monitoring of blood sugar is important in ensuring glycemic control and preventing hyperglycemia and asymptomatic hypoglycemia. Reiki is applied as an alternative and complementary treatment method. Reiki application, when used together with pharmacological methods, chronic fatigue, diabetic neuropathy, pain caused by surgery, cancer treatment, symptoms of cardiovascular diseases, emotional disorders such as anxiety, depression, acute or chronic pain, infertility-related problems, neurodegenerative disorders, AIDS, autism and developmental disorders, Crohn's disease, irritable bowel syndrome, traumatic brain injury and has been shown to improve health problems such as fatigue. In the literature, the effects of reiki have been examined in patient groups with different chronic diseases, but no study has been found on obese individuals with Type 2 diabetes. Therefore, reikinin in obese individuals with Type 2 diabetes; This study is planned to determine whether it has an effect on compliance with diabetes treatment, eating behaviors, anxiety levels and changes in metabolic values.
Status | Recruiting |
Enrollment | 1 |
Est. completion date | November 1, 2023 |
Est. primary completion date | July 15, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Having been diagnosed with Type 2 diabetes at least 6 months ago, 2. Body mass index = 30 kg/m² 3. Being on oral therapy or using insulin, 4. Ability to communicate and read, 5. Volunteering to participate in research Exclusion Criteria: 1. Not complying with the principle of voluntarism 2. Answering data collection forms incompletely 3. Desire to leave the study at any stage of the study |
Country | Name | City | State |
---|---|---|---|
Turkey | Harran Unv | Sanliurfa | |
Turkey | Harran unv. | Sanliurfa |
Lead Sponsor | Collaborator |
---|---|
Hasan Kalyoncu University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | "Reiki has a positive effect on adherence to treatment, eating behaviors and metabolic values in obese individuals with type 2 diabetes. | Metabolic changes in the patient before and after reiki | 12 weeks | |
Primary | Blood glucose level | HbA1c change in the patient before and after reiki | 12 weeks | |
Primary | Blood cholesterol level | Blood cholesterol exchange level | 12 weeks | |
Primary | Blood pressure | Blood pressure status | 12 weeks | |
Primary | Body mass index | Body mass index change | 12 weeks | |
Primary | Belly circumference measurement | waist circumference will be measured with a tape measure | 12 weeks | |
Primary | Anxiety level change | TO BE EVALUATED BY SCALE | 12 weeks | |
Primary | Change in eating behavior | The change in eating behavior will be evaluated with a scale | 12 weeks | |
Primary | Change in adherence to treatment | change in adherence to treatment will be evaluated with a scale | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02668328 -
Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients
|
N/A | |
Completed |
NCT04314427 -
Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS
|
||
Not yet recruiting |
NCT06333132 -
Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat)
|
N/A | |
Active, not recruiting |
NCT05579561 -
Vegetarian Ketogenic Diet VS Omnivore Ketogenic Diet - Protocol of a Keto-vege Diet for Remission of Type 2 Diabetes
|
N/A | |
Completed |
NCT02938026 -
Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle Counselling
|
N/A | |
Recruiting |
NCT05887271 -
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
Completed |
NCT02680873 -
Efficacy of SASI Bypass for Type-2 Diabetic Obese Patients
|
N/A | |
Completed |
NCT01364350 -
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
|
||
Not yet recruiting |
NCT05711043 -
The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
|
N/A | |
Completed |
NCT02784275 -
A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT01874366 -
Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
|
Phase 1 | |
Recruiting |
NCT03821636 -
Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.
|
N/A | |
Recruiting |
NCT03904901 -
Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight
|
N/A | |
Active, not recruiting |
NCT01989988 -
DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM
|
N/A | |
Completed |
NCT02122874 -
Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients
|
Phase 3 | |
Completed |
NCT03394157 -
Randomized Comparative Study of Sleeve Gastrectomy Versus MGB and SASI Bypass , Randomized Study
|
N/A | |
Recruiting |
NCT04227769 -
IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
|
Phase 2 | |
Active, not recruiting |
NCT05755321 -
From Skin Fibroblasts to Neural Stem Cells to Investigate in Vitro the Impact of Diabetes on Adult Neurogenesis
|
||
Completed |
NCT04957589 -
VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men
|
N/A | |
Recruiting |
NCT05801614 -
Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction
|
N/A |